Statistics In the Pharmaceutical Industry
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Weitere Titel der Reihe: Chapman & Hall/CRC Biostatistics Series
Alle anzeigenMedical Statistics for Cancer Studies
Taylor and Francis, 2024
978-1-032-28587-0
79.00 CHF
sofort lieferbar
Statistical Analytics for Health Data Science with SAS and R
Taylor and Francis, 2023
978-1-03-232562-0
ca. 140.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Methods in Health Economics
Taylor and Francis, 2023
978-1-03-247753-4
ca. 80.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Data Science, AI, and Machine Learning in Drug Development
Taylor and Francis, 2022
978-0-367-70807-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2020
978-0-367-73187-8
ca. 86.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare
Taylor and Francis, 2020
978-0-367-36292-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2019
978-1-138-73173-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
An Applied Approach Using SAS & STATA
Taylor and Francis, 2015
978-1-4665-0547-6
ca. 146.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Benefit-Risk Assessment in Pharmaceutical Research and Development
Taylor and Francis, 2013
978-1-4398-6794-5
ca. 156.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Weitere Titel zum Thema
Derivatives
Mathematical Foundations for Finance Students
Taylor and Francis, 2026
978-1-032-76219-7
ca. 209.00 CHF
erscheint im Juni
Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease ...
Elsevier, 2026
978-0-443-43946-9
ca. 260.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Mitochondria-targeted Drug Delivery Strategies for Cancer Therapy
Elsevier, 2026
978-0-443-40479-5
ca. 275.00 CHF
erscheint im Juli
Topical Dermal Drug Delivery
Concepts and Advances
Elsevier, 2026
978-0-443-21945-0
ca. 215.00 CHF
erscheint im Juli
Variably Legal Markets
Rethinking Markets and Crime
Taylor and Francis, 2026
978-0-367-18613-5
ca. 249.00 CHF
erscheint im März
Innovative Nanocarriers for Stimulated Drug Delivery
A Comprehensive Guide to Stimuli-responsive Nanoparticles
Elsevier, 2026
978-0-443-33641-6
ca. 255.00 CHF
erscheint im Juni
Count Time Series
A Generalized Linear Models Approach
Taylor and Francis, 2027
978-1-4822-4805-0
ca. 130.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Theory of Sampling and Sampling Practice
Taylor and Francis, 2026
978-1-032-83008-7
ca. 316.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Multi-Criteria Decision-Making
Principles, Methods and Programs
Taylor and Francis, 2026
978-1-032-85363-5
ca. 159.00 CHF
erscheint im März
The Analysis of Time Series
An Introduction with R
Taylor and Francis, 2026
978-1-041-08586-7
ca. 285.00 CHF
erscheint im August
Off the Scales
The Inside Story of Ozempic and the Race to Cure Obesity
Harper Collins, 2026
978-0-00-871909-8
30.90 CHF
sofort lieferbar
Cornerstones in Quantitative Empirical Methods
Volume 1: Foundations
Taylor and Francis, 2026
978-1-032-96772-1
ca. 155.00 CHF
lieferbar in ca. 10-20 Arbeitstagen